Jones Day is well-equipped to handle complex high-value, cross-jurisdictional transactions for notable Belgian and international private equity funds. The practice is headed by M&A and capital markets expert Pierre-Olivier Mahieu, who joined from A&O Shearman and brings notable experience assisting on pharmaceutical sector transactions. Jonas Van den Bossche is a further key contact. Thomas De Muynck left the firm in November 2025.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Key clients
- Arsenal Capital Partners
- BioFirst
- CellCarta Biosciences
- Fortino Capital
- For Talents Transmission
- Hi Inov Capital
- iSTAR Medical
- Pandox
- Partech Capital
- Ring Capital
- Stride.VC
- The Riverside Company
Work highlights
Advised Fortino Capital on the exit of its portfolio company Mobilexpense to Norwegian software group Visma.
Advised Stride.VC on the sale, together with its co-investors, of Belgian company Accountable to Norwegian software group Visma.
Advised iStar Medical SA on its financing round subscribed by GIMV, EQT, Earlybird Ventures,Capricorn and others.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Pierre-Olivier Mahieu
Other key lawyers
Jonas Van den Bossche